CAPTRUST Financial Advisors’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-319
Closed -$1K 4496
2022
Q2
$1K Hold
319
﹤0.01% 4828
2022
Q1
$1K Hold
319
﹤0.01% 4806
2021
Q4
$3K Hold
319
﹤0.01% 4336
2021
Q3
$2K Hold
319
﹤0.01% 4329
2021
Q2
$2K Buy
+319
New +$2.01K ﹤0.01% 4234

Other funds holding LHDX

CAPTRUST Financial Advisors's LHDX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 319 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in LHDX in Q2 2021 and held it in 5 quarters. The position peaked at $3K in Q4 2021. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 319 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Lucira Health, Inc. Common Stock position peaked at $3K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.